Comments to FDA: Antiplaque, Antigingivitis Share page: Docket Number: 81N-033P Comments regarding "Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph". Download Document Issues: OTC Medicines Related Posts Regulation of OTC Medicines Press Releases and Statements CHPA Congratulates Dr. Doug Bierer as First Recipient of the William Cooley Regulatory & Scientific Affairs Career Achievement Award Sep 18, 2024 Press Releases and Statements Health In Hand Foundation Announces 2024 U.S. Self-Care Marketing Awards Finalists Sep 9, 2024